MAP2K1 and T-cell large granular lymphocyte leukemia: Whether activated by PDGF pathways or other mechanisms (see also below), RAS-RAF-MEK1-ERK signaling is hyperactive in LGLL (particularly in the NK subtype), and its inhibition showed encouraging results in this setting via restoration of Fas sensitivity [23,29].